Image

SHUTTERSTOCK
Image

An epic tug of war is playing out behind the scenes over whether the government should pay for Aduhelm, a controversial Alzheimer’s drug that scientists say has not been proven to work./Lydia Zuraw/KHN
Image

Shutterstock
Image

SHUTTERSTOCK
Image

GLOBAL PANORAMA/CREATIVE COMMONS